Phenazopyridine
Sponsors
EMS, Hartford Hospital, Cecilia Calvo, Johns Hopkins University, Boston Urogynecology Associates
Conditions
CystoscopyDetrusor HyperreflexiaDetrusor InstabilityDysfunctional VoidingDysuriaInjury of UreterIntraoperative CystoscopyOveractive Bladder
Phase 3
Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria
CompletedNCT01657448
Start: 2016-06-27End: 2017-12-22Updated: 2020-07-07
The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)
CompletedNCT02806713
Start: 2016-02-29End: 2017-08-31Updated: 2019-02-05
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
CompletedNCT03065075
Start: 2017-02-01End: 2019-02-28Updated: 2019-04-16
Phase 4
Assessing Pyridium for Post-Sling Urinary Retention
CompletedNCT03302936
Start: 2017-10-24End: 2019-07-01Updated: 2019-10-29
Oral vs Intravesical Analgesia for Office Bladder Botox Injections
NCT03755089
Start: 2018-11-01End: 2021-03-01Target: 110Updated: 2020-05-29
Prophylactic Analgesia for Bladder Botox Injections
WithdrawnNCT06514430
Start: 2025-07-31End: 2026-02-28Updated: 2025-07-18
Unknown Phase
Phenazopyridine for Confirmation of Ureteral Patency
CompletedNCT02424149
Start: 2015-04-30End: 2016-01-31Updated: 2016-12-05
Evaluation of Ureteral Jets on Cystoscopy
CompletedNCT02476448
Start: 2015-02-28End: 2016-07-31Updated: 2019-10-23
Evaluation of Fluorescein Use During Cystoscopy
WithdrawnNCT02703558
Start: 2016-03-31End: 2018-01-10Updated: 2018-01-12
Using Phenazopyridine for In-office Cystoscopy
NCT02715648
Start: 2016-04-01End: 2021-06-01Target: 94Updated: 2020-12-31
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
WithdrawnNCT02757417
Start: 2016-07-31End: 2019-12-31Updated: 2022-05-06